Covid-19 News

COVID-19

• Communicable disease threats report, 18-24 October 2025, week 43 October 24, 2025
  This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 18-24 October 2025, and includes updates on respiratory viruses, monkeypox virus clade Ib, Ebola virus disease, dengue, West Nile virus infection, chikungunya virus disease, and expert deployments.
• ECDC: On Air - Episode 67 - Angeliki Melidou - Winter Viruses: The triple threat explained October 22, 2025
  In this episode of ECDC On Air, we discuss the seasonal spread of respiratory viruses with ECDC's Principal Expert in Respiratory Viruses - Angeliki Melidou.
• Mythbusting: Protect yourself against the flu, RSV and COVID-19 October 21, 2025
  Infographic on protecting yourself and the most vulnerable against respiratory viruses.
• How to protect your community from respiratory viruses October 21, 2025
  Infographic on the risks posed by respiratory viruses and how to protect your community from infection.
• ECDC urges immunisation and other measures as Europe enters respiratory virus season October 20, 2025
  As Europe enters the autumn and winter months, respiratory infections are expected to considerably affect the health of individuals vulnerable to severe outcomes.
• COVID-19 vaccine effectiveness in the paediatric population aged 5-17 years: a multicentre cohort study using electronic health registries in six European countries, 2021 to 2022 October 20, 2025
  During the first year of the COVID-19 pandemic, vaccination programmes targeted children and adolescents to prevent severe outcomes of SARS-CoV-2 infection.AimTo estimate COVID-19 vaccine effectiveness (VE) against hospitalisation due to COVID-19 in the paediatric population, among those with and without previously documented SARS-CoV-2 infection.
• Effectiveness of XBB.1.5 Vaccines Against Symptomatic SARS-CoV-2 Infection in Older Adults During the JN.1 Lineage-Predominant Period, European VEBIS Primary Care Multicentre Study, 20 November 2023-1 March 2024 October 20, 2025
  We estimated XBB.1.5 vaccine effectiveness (VE) against symptomatic SARS-CoV-2 infection among adults aged ≥ 65 years during the 2023/2024 JN.1 lineage-predominant period in a European multi-country test-negative case-control study at primary care level.
• Communication tools on COVID-19 October 17, 2025
  Communications materials, toolkits and guidelines on COVID-19.
• Weekly respiratory virus update, week 41, October 2025 October 17, 2025
  There is still widespread circulation of COVID-19 in the EU/EEA, although it is decreasing. RSV and influenza transmission remain low — for now. Consider getting vaccinated against seasonal respiratory viruses.
• The European Respiratory Virus Surveillance Summary (ERVISS) October 10, 2025
  This interactive dashboard provides a weekly integrated epidemiological summary for influenza, RSV and SARS-CoV-2.